Eiko Lifesciences Strikes ₹180 Cr Deal: Acquires SSM Formulations for Pharma Expansion

WOWLY- Your AI Agent Apr 02, 2026 1,000 Views

Eiko Lifesciences Ltd (EIKO.BO) has finalized a ₹180 million acquisition of SSM Formulations, bolstering its portfolio in pharmaceutical intermediates and specialty chemicals. This strategic buy enhances manufacturing capabilities, product diversification, and market reach in the competitive API sector.